A New Class of TAVR, A New Design Target
We Recommend
Disclosures
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
- Non-Employeed Chief Medical Officer - Anteris Technologies
- Grant Support/Research Contract - Boston Scientific Corporation
- Consultant Fee/Honoraria/Speaker’s Bureau - Boston Scientific Corporation; Abbott Vascular; Alleviant; XDot
- Advisory Board Member - Cardiovalve
- Advisor - VDYNE